These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21820020)

  • 1. In vivo tropisms and kinetics of rat theilovirus infection in immunocompetent and immunodeficient rats.
    Drake MT; Besch-Williford C; Myles MH; Davis JW; Livingston RS
    Virus Res; 2011 Sep; 160(1-2):374-80. PubMed ID: 21820020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential susceptibility of SD and CD rats to a novel rat theilovirus.
    Drake MT; Riley LK; Livingston RS
    Comp Med; 2008 Oct; 58(5):458-64. PubMed ID: 19004372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a duplex real-time RT-PCR for the simultaneous detection and differentiation of Theiler's murine encephalomyelitis virus and rat theilovirus.
    Yuan W; Wang J; Xu F; Huang B; Lian Y; Rao D; Yin X; Wu M; Zhu Y; Zhang Y; Huang R; Guo P
    J Virol Methods; 2016 Oct; 236():139-146. PubMed ID: 27396678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of an outbreak of rat theilovirus.
    Dyson MC
    Lab Anim (NY); 2010 May; 39(5):155-7. PubMed ID: 20410900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Jin YH; Kang HS; Hou W; Meng L; Kim BS
    J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restraint stress facilitates systemic dissemination of Theiler's virus and alters its pathogenecity.
    Mi W; Young CR; Storts RW; Steelman AJ; Meagher MW; Welsh CJ
    Microb Pathog; 2006; 41(4-5):133-43. PubMed ID: 16949789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential induction of IL-10 in APC correlates with a switch from Th1 to Th2 response following infection with a low pathogenic variant of Theiler's virus.
    Palma JP; Yauch RL; Kang HK; Lee HG; Kim BS
    J Immunol; 2002 Apr; 168(8):4221-30. PubMed ID: 11937584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Burt RK; Padilla J; Dal Canto MC; Miller SD
    Blood; 1999 Oct; 94(8):2915-22. PubMed ID: 10515897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.
    Kim BS
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.
    Zheng L; Calenoff MA; Dal Canto MC
    J Neuroimmunol; 2001 Aug; 118(2):256-67. PubMed ID: 11498260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus.
    Azoulay-Cayla A; Dethlefs S; Pérarnau B; Larsson-Sciard EL; Lemonnier FA; Brahic M; Bureau JF
    J Virol; 2000 Jun; 74(12):5470-6. PubMed ID: 10823851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL; Dal Canto MC; Bluestone JA; Miller SD
    J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Persistentent infection and demyelination induced by Theiler's murine encephalomyelitis virus (TMEV)].
    Ohara Y
    Uirusu; 1999 Dec; 49(2):175-81. PubMed ID: 10737115
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody.
    Inoue A; Koh CS; Yamazaki M; Yahikozawa H; Ichikawa M; Yagita H; Kim BS
    J Immunol; 1998 Nov; 161(10):5586-93. PubMed ID: 9820536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.
    Steurbaut S; Rombaut B; Vrijsen R
    J Neurovirol; 2007; 13(1):47-55. PubMed ID: 17454448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis.
    Tsunoda I; Fujinami RS
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):355-69. PubMed ID: 19894121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection.
    Kirkman NJ; Libbey JE; Wilcox KS; White HS; Fujinami RS
    Epilepsia; 2010 Mar; 51(3):454-64. PubMed ID: 19845729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real-time RT-PCR.
    Trottier M; Schlitt BP; Lipton HL
    J Virol Methods; 2002 May; 103(1):89-99. PubMed ID: 11906736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane lymphotoxin is required for resistance to Theiler's virus infection.
    Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP
    Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.